Frontiers in Neuroscience
GLP-1 and GIP class drugs have neuroprotective properties in Alzheimer's and Parkinson's disease
ReviewInterventions
Papers by Christian Hölscher
2 results
- ADA Scientific Sessions 2025 Abstract
Oral Small Molecule GLP-1 Receptor Agonist Demonstrates Beneficial Effects in Parkinson's Disease–Like Model Using Humanized GLP-1R Mice
Experiments in animalsInterventions